NCT01166672

BCRL Prevention Pilot

Weight Loss to Prevent BCRL: A Pilot Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 20 (estimated)
• Sponsor: Abramson Cancer Center at Penn Medicine · Academic / Other
• Sex: Female
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to establish feasiblity of recruiting obese breast cancer survivors at the end of treatment, getting those survivors to lose weight and attend follow-up visits for 6 months.

Detailed description

Breast cancer related lymphedema occurs in 20-30% of survivors. Weight loss could prevent onset. We seek to do a pilot study to establish feasibility of 1) recruiting survivors at risk for lymphedema to do a weight loss intervention, 2) achieving 10-15% weight loss over 26 weeks in this population, and 3) attendance at follow-up visits 6 months.

Conditions

• Obesity
• Breast Cancer

Timeline

• Start date: 2010-07-01
• Primary completion: 2012-10-01
• Completion: 2012-10-01
• First posted: 2010-07-21
• Last updated: 2012-10-12

Locations

1 site across 1 country: United States